Alex Gordon
About Alex Gordon
Alex Gordon is the CEO and co-founder of Revolve Surgical, a company focused on low-cost robotic surgery. He has a background in biomedical engineering and mechatronics, with previous experience at Multimatic Inc. and The Hospital for Sick Children.
Work at Revolve Surgical
As the CEO and co-founder of Revolve Surgical, Alex Gordon has been instrumental in driving the company's mission to innovate in the field of robotic surgery. Since its inception in 2019, Revolve Surgical has focused on developing a hybrid manual-robotic surgical platform. This platform aims to significantly reduce the size, cost, and training requirements associated with traditional surgical robots. Under Gordon's leadership, the company has made strides in pioneering advancements in low-cost robotic surgery, positioning itself as a key player in the medical technology sector.
Education and Expertise
Alex Gordon holds a Bachelor of Applied Science (BASc) degree from the University of Toronto, where he studied Solid Mechanics, Mechatronics & Robotics, and Engineering Business from 2009 to 2013. He furthered his education at the same institution, earning a Doctor of Philosophy (PhD) in Biomedical/Medical Engineering from 2016 to 2021. This strong educational background provides him with a solid foundation in engineering principles and medical technology, which he applies in his current role at Revolve Surgical.
Background
Before co-founding Revolve Surgical, Alex Gordon gained valuable experience in various engineering roles. He worked as a Structures and Mechanisms Engineer at Multimatic Inc. from 2014 to 2016, where he developed skills in engineering design. He also served as a Biomedical Engineer at The Hospital for Sick Children from 2017 to 2020, contributing to healthcare technology. Additionally, he was a Teaching Assistant in Engineering Design at the University of Toronto from 2017 to 2019, where he supported students in their engineering education.
Achievements
Alex Gordon co-founded Revolve Surgical, which was part of the Y Combinator Summer 2021 batch, indicating a recognition of the company's potential in the startup ecosystem. His involvement in the Creative Destruction Lab as a CDL Alumni in the Health Stream from 2019 to 2020 further highlights his commitment to advancing healthcare technology. Through these initiatives, Gordon has demonstrated a focus on innovation and the application of engineering principles to improve surgical practices.